Turk Ilac ve Serum Sanayi AS (TRILC) - Total Liabilities

Latest as of September 2025: TL4.21 Billion TRY ≈ $94.36 Million USD

Based on the latest financial reports, Turk Ilac ve Serum Sanayi AS (TRILC) has total liabilities worth TL4.21 Billion TRY (≈ $94.36 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Turk Ilac ve Serum Sanayi AS annual equity growth to track the company's year-over-year net asset growth rate.

Turk Ilac ve Serum Sanayi AS - Total Liabilities Trend (2018–2024)

This chart illustrates how Turk Ilac ve Serum Sanayi AS's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Turk Ilac ve Serum Sanayi AS generate to measure how efficiently the company converts operating cash flow to free cash.

Turk Ilac ve Serum Sanayi AS Competitors by Total Liabilities

The table below lists competitors of Turk Ilac ve Serum Sanayi AS ranked by their total liabilities.

Company	Country	Total Liabilities
Katapult Holdings Inc NASDAQ:KPLT	USA	$108.02 Million
MoneyHero Limited Class A Ordinary Shares NASDAQ:MNY	USA	$37.48 Million
Radiant Globaltech Bhd KLSE:0202	Malaysia	RM66.12 Million
D P Wires Limited NSE:DPWIRES	India	Rs-2.48 Billion
UCAL Limited NSE:UCAL	India	Rs4.93 Billion
Dongbang Ship Machinery Co. Ltd KQ:099410	Korea	₩17.09 Billion
American West Metals Ltd AU:AW1	Australia	AU$13.81 Million
Kincora Copper Ltd V:KCC	Canada	CA$733.00K

Liability Composition Analysis (2018–2024)

This chart breaks down Turk Ilac ve Serum Sanayi AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Turk Ilac ve Serum Sanayi AS (TRILC) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.16	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.20	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.69	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Turk Ilac ve Serum Sanayi AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Turk Ilac ve Serum Sanayi AS (2018–2024)

The table below shows the annual total liabilities of Turk Ilac ve Serum Sanayi AS from 2018 to 2024.

Year	Total Liabilities	Change
2024-12-31	TL2.07 Billion ≈ $46.38 Million	+98.32%
2023-12-31	TL1.04 Billion ≈ $23.39 Million	+117.69%
2022-12-31	TL479.65 Million ≈ $10.74 Million	+62.34%
2021-12-31	TL295.46 Million ≈ $6.62 Million	+17.71%
2020-12-31	TL250.99 Million ≈ $5.62 Million	+24.35%
2019-12-31	TL201.84 Million ≈ $4.52 Million	+58.46%
2018-12-31	TL127.38 Million ≈ $2.85 Million	--

About Turk Ilac ve Serum Sanayi AS

IS:TRILC Turkey Drug Manufacturers - Specialty & Generic

Market Cap

$27.87 Million

TL1.24 Billion TRY

Market Cap Rank

#23986 Global

#417 in Turkey

Share Price

TL1.20

Change (1 day)

+0.00%

52-Week Range

TL1.13 - TL25.26

All Time High

TL37.80